ALPS Advisors’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$238K Sell
2022
Q4
$324K Buy
2022
Q3
$401K Buy
2022
Q2
$151K Sell
2022
Q1
$453K Sell
2021
Q4
$975K Sell
2021
Q3
$2M Sell
2021
Q2
$1.69M Sell
2021
Q1
$2.76M Buy
2020
Q4
$4.52M Buy